Human studies have shown that butyrate producing bacteria, such as Roseburia, are less abundant in subjects with T2D (60–62), indicating the need of butyrate producing bacteria for normal glycemic regulation and butyrate supplementation in rodents has been shown to improve insulin sensitivity (63) and glucose homeostasis (64). The gene discussed is INS; the disease is type 2 diabetes mellitus.